AADI | Aadi Bioscience, Inc. | -46.25% | -33.73% | 0.00% | 94.17% | -93.19% | -0.49 |
---|
ABCL | AbCellera Biologics Inc. | -29.30% | -68.16% | 0.00% | 81.40% | -90.29% | -0.72 |
---|
ABCM | Abcam plc | -38.98% | -17.26% | 0.00% | 38.20% | -47.78% | -0.72 |
---|
ABEO | Abeona Therapeutics Inc. | -41.18% | -40.05% | 0.00% | 108.24% | -99.91% | -0.96 |
---|
ABIO | ARCA biopharma, Inc. | 16.28% | -39.27% | 0.00% | 155.21% | -99.97% | -0.58 |
---|
ABOS | Acumen Pharmaceuticals, Inc. | -27.81% | N/A | 0.00% | 73.46% | -84.81% | N/A |
---|
ABSI | Absci Corporation | -57.80% | N/A | 0.00% | 99.07% | -89.67% | N/A |
---|
ABUS | Arbutus Biopharma Corporation | -30.59% | 2.50% | 0.00% | 95.28% | -97.19% | -0.17 |
---|
ABVC | ABVC BioPharma, Inc. | -69.03% | -86.34% | 0.00% | 1,220.91% | -100.00% | -0.43 |
---|
ACAD | ACADIA Pharmaceuticals Inc. | -39.07% | 23.30% | 0.00% | 81.91% | -77.18% | -0.56 |
---|
ACER | Acer Therapeutics Inc. | -43.42% | -35.73% | 0.00% | 128.41% | -99.88% | -0.84 |
---|
ACET | Adicet Bio, Inc. | -16.64% | -37.72% | 0.00% | 95.52% | -95.80% | 0.50 |
---|
ACHL | Achilles Therapeutics plc | -50.10% | -78.06% | 0.00% | 73.18% | -89.03% | -1.02 |
---|
ACHV | Achieve Life Sciences, Inc. | -34.83% | -58.08% | 0.00% | 89.17% | -99.99% | -0.88 |
---|
ACIU | AC Immune SA | -26.67% | -22.45% | 0.00% | 78.83% | -87.82% | -0.81 |
---|
ACOR | Acorda Therapeutics, Inc. | -81.31% | -43.83% | 0.00% | 76.19% | -99.89% | -0.88 |
---|
ACRS | Aclaris Therapeutics, Inc. | -1.24% | 3.98% | 0.00% | 114.59% | -97.73% | -0.26 |
---|
ACXP | Acurx Pharmaceuticals, Inc. | -15.99% | -39.14% | 0.00% | 86.95% | -69.33% | -0.53 |
---|
ADAG | Adagene Inc. | -74.03% | -85.36% | 0.00% | 73.08% | -93.36% | -1.12 |
---|
ADAP | Adaptimmune Therapeutics plc | -54.40% | -26.88% | 0.00% | 117.86% | -96.57% | -0.77 |
---|